Changing the Future of Addiction Care | Breakthroughs Can’t Wait with Dr. Sarah Kattakuzhy
Can a class of drugs best known for treating diabetes and weight loss also help people struggling with cocaine use disorder?Dr. Sarah Kattakuzhy, an associate professor at the University of Maryland School of Medicine, is leading innovative research on GLP-1 receptor agonists — medications that may offer a new path forward in treating addiction.This NIH-funded research could transform how we understand and address substance use, giving people more options — and more hope.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs#BreakthroughsCantWait #AddictionResearch #CocaineUseDisorder #GLP1 #SubstanceUseDisorder #UMBResearch #NIHfunding #HealthInnovation #DrSarahKattakuzhy
More from Youtube
- 0:53How Malaria Research Saves Children’s Lives | Breakthroughs Can't WaitEvery child deserves a safe and thriving future.At the University of Maryland School of Medicine, Dr. Matthew Laurens is helping lead global research to improve childhood health — with support from the National Institute of Allergy and Infectious Diseases (NIAID).#ChildHealth #GlobalHealth #NIAID #MedicalResearch #PublicHealth #BreakthroughsCantWaitUMB
- 0:50Making Sure Malaria Doesn't Come Back Home | Breakthroughs Can't WaitMalaria isn’t just a global problem — it’s a growing concern here at home. Dr. Matthew Laurens from the University of Maryland School of Medicine explains the risks of malaria’s return to the U.S. and how prevention research is making a difference.#MalariaAwareness #GlobalHealth #DiseasePrevention #MedicalResearch #UMBSOM #BreakthroughsCantWaitUMB
